REFERENCES
- Anderson S, Meyer TW, Rennke HG, Brenner BM, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest 1985; 76: 612.
- Ando K, Fujita T, Sto Y, Noda H, Vamashita K, The role of renal hemodynamics in the antihypertensive effect of captopril, Am Heart J 1986; 111: 347.
- Bauer JH, Jones LB, Comparative studies, Enalapril vs, hydrochlorothiazide as first-step therapy for the treatment of primary hypertension, Am J Kidney Dis 1984; 4: 55.
- Beukers J, Van der Wal A, Philip J, Hoedemaeker P, Weening J, Converting enzyme inhibition and progressive glomerulosclerosis in the rat, Kidney Int 1987; 32: 794.
- Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M, Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetes nephropathy, Br Med J 1986; 293: 471.
- Bohrer MP, Deen WM, Robertson CR, Brenner BM, Mechanism of angiotensin II-induced proteinuria in the rat, Am J Physiol 1977; 233: F 13.
- Cameron JS, Mechanism of progression in glomerulonephritis, Proc EDTA 1982; 19: 617.
- Deodhar SD, Cuppage FE, Gableman E, Studies on the mechanism of experimental proteinuria induced by renin, J Exp Med 1964; 120: 677.
- Heeg JE, De Jong PE, Van der Hem GK, De Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition, Kidney Int 1987; 32: 78.
- Heeg JE, De Zeeuw D, De Jong PE, Antiproteinuric effect of ACE inhibitors, Lancet 1988; 2: 1251.
- Heinegård D, Tideström G, Determination of serum creatinine by a direct colorimetric method, Clin Chim Acta 1973; 43: 305.
- Herlitz H, Edenö C, Mulec H, Westberg G, Aurell M, Captopril treatment of hypertension and renal failure in systemic lupus erythematosus, Nephron 1984; 38: 253.
- Lim H, Kamide R, Gigli I, Effect of captopril on the vascular permeability changes induced by C5a, histamine and compound 48/80, Br J Derm 1985; 112: 43.
- Marre M, Leblac H, Suarez L, Guyenne TT, Ménard J, Passa P, Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria, Br Med J 1987; 294: 1448.
- Meyer TW, Anderson S, Rennke HG, Brenner B, Converting enzyme inhibitor therapy limits glomerular injury in rats with renal insufficiency, Am J Med 1985; 79 (Suppl 3C): 31.
- Pasternak A, Eklund J, Krohn K, Renal artery stenosis and the nephrotic syndrome, Acta Med Scand 1967; 181: 265.
- Raij L, Chiou XC, Owens R, Wrigley B, Therapeutic implications of hypertension-induced glomerular injury, Am J Med 1985; 79: 37.
- Reams GP, Bauer JH, Effect of enalpril in subjects with hypertension associated with moderate to severe renal dysfunction, Arch Intern Med 1986; 146: 2145.
- Simon G, Morioka S, Snyder DK et al, Increased renal plasma flow in long-term enalapril treatment of hypertension, Clin Pharmacol Ther 1983; 34: 459.
- Steinhansen M, Köcherer H, Parckh N, Weis S, Wiegman DL, Wilhelm KR, Angiotensin II control of the renal microcirculation: Effect of blockade by saralasin, Kidney Int 1986; 30: 56.
- Taguma Y, Kitamoto Y, Futaki G et al, Effect of captopril on heavy proteinuria in azotemic diabetics, N Engl J Med 1985; 313: 1617.
- Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I, Role for angiotensin II in an overt functional proteinuria, Kidney Int 1986; 30: 538.
- Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest 1986; 77: 1925.
- Letters to the Editor, N Engl J Med 1986; 315: 515.